UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The implications of hypersomnia in the context of major depression: Results from a large, international, observational study

European neuropsychopharmacology, 2019-04, Vol.29 (4), p.471-481

2019

Volltextzugriff (PDF)

C.04.03 Treating the whole patient: understanding the complexities of bipolar disorder

European neuropsychopharmacology, 2009, Vol.19, p.S708-S708

Bowden, C

2009

Volltextzugriff (PDF)

Hypomanic symptoms in mixed depression: is DSM-5 wrong? Evidence from the BRIDGE-II MIX study

European neuropsychopharmacology, 2016-10, Vol.26, p.S432-S432

2016

Volltextzugriff (PDF)

P.3.e.014 VALID: a 12-week, open, randomised trial of valproate and lithium in bipolar I patients suffering from a manic episode

European neuropsychopharmacology, 2007, Vol.17, p.S494-S494

Bowden, C

2007

Volltextzugriff (PDF)

Lamotrigine in the treatment of bipolar depression

European neuropsychopharmacology, 1999-08, Vol.9, p.S113-S117

1999

Volltextzugriff (PDF)

Psychomotor symptoms in major depressive episode are related to bipolarity. A pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts

European neuropsychopharmacology, 2019, Vol.29, p.S353-S355

2019

Volltextzugriff (PDF)

P.332 Deconstructing major depressive episodes by severity and chronicity: A cross-diagnostic cluster-analysis on a large, international, observational study

European neuropsychopharmacology, 2019-12, Vol.29, p.S237-S238

2019

Volltextzugriff (PDF)

C.17.02 Valproate in mania: from Pierre Lambert to New Deli Study

European neuropsychopharmacology, 2006, Vol.16, p.S587-S587

Bowden, C.

2006

Volltextzugriff (PDF)

P.2.e.016 Sensitivity of a comprehensive rating scale for bipolar disorders to assess improvements with treatment

European neuropsychopharmacology, 2009, Vol.19, p.S457-S458

2009

Volltextzugriff (PDF)

E.04.02 The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines

European neuropsychopharmacology, 2009, Vol.19, p.S221-S222

2009

Volltextzugriff (PDF)

P.3.a.030 A 6-month, double-blind trial of ziprasidone plus a mood stabilizer in subjects with bipolar I disorder

European neuropsychopharmacology, 2009, Vol.19, p.S497-S498

2009

Volltextzugriff (PDF)

P.2.e.026 Valproate for acute bipolar depression: systematic review and meta-analysis

European neuropsychopharmacology, 2009, Vol.19, p.S463-S463

2009

Volltextzugriff (PDF)

Lamotrigine in bipolar depression and rapid cycling

European neuropsychopharmacology, 2001, Vol.11, p.S94-S95

Bowden, C.

2001

Volltextzugriff (PDF)

Advances on prophylactics of bipolar disorder

European neuropsychopharmacology, 1998-11, Vol.8, p.S69-S70

Bowden, C.

1998

Volltextzugriff (PDF)

Risperidone treatment for acute mania: assessment of tolerability

European neuropsychopharmacology, 2000-09, Vol.10, p.246-246

2000

Volltextzugriff (PDF)

P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorder

European neuropsychopharmacology, 2007, Vol.17, p.S388-S389

2007

Volltextzugriff (PDF)

P.1.210 Concomitant use of lamotrigine and valproate in bipolar I disorder

European neuropsychopharmacology, 2003-10, Vol.13, p.S264-S264

2003

Volltextzugriff (PDF)

P.1.212 Effects of lithium and lamotrigine on body weight after 18 months in bipolar I disorder

European neuropsychopharmacology, 2003-10, Vol.13, p.S265-S265

2003

Volltextzugriff (PDF)

Adjunctive risperidone in acute mania: A combined efficacy analysis

European neuropsychopharmacology, 2001, Vol.11, p.S249-S249

2001

Volltextzugriff (PDF)

Risperidone plus mood stabilizer versus placebo plus mood stabilizer in patients with bipolar disorder: A combined efficacy analysis

European neuropsychopharmacology, 2001, Vol.11, p.S254-S254

2001

Volltextzugriff (PDF)

Use of risperidone in psychotic and non-psychotic patients with bipolar disorder

European neuropsychopharmacology, 2000-09, Vol.10, p.281-281

2000

Volltextzugriff (PDF)

ECNP Consensus Meeting March 2000 Nice: Guidelines for Investigating Efficacy in Bipolar Disorder

European neuropsychopharmacology, 2001, Vol.11 (1), p.79-88

2001

Volltextzugriff (PDF)

P.1.216 Lamotrigine but not lithium prevents or delays depressive episodes in bipolar I disorder

European neuropsychopharmacology, 2003-10, Vol.13, p.S266-S267

2003

Volltextzugriff (PDF)

P.1.217 Predictors of response to lithium and lamotrigine prophylaxis in bipolar I disorder

European neuropsychopharmacology, 2003-10, Vol.13, p.S267-S267

2003

Volltextzugriff (PDF)

P.1.213 Safety and tolerability of lamotrigine in bipolar I disorder

European neuropsychopharmacology, 2003-10, Vol.13, p.S265-S265

2003

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieEuropean Neuropsychopharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Psychiatry
(11)
Internal Medicine
(8)
Clinical Neurology
(3)
Life Sciences & Biomedicine
(3)
Neurosciences
(3)
Neurosciences & Neurology
(3)
Pharmacology & Pharmacy
(3)
Science & Technology
(3)
Bipolar Depression
(2)
Humans
(2)
[ 3h]gbr12935 Binding
(1)
Acetates
(1)
Acetates - Therapeutic Use
(1)
Adolescent
(1)
Adult
(1)
Affect - Drug Effects
(1)
Aged
(1)
Amines
(1)
Antidepressant Drug
(1)
Antidepressive Agents - Therapeutic Use
(1)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(32)
Ingenta
(32)
Elsevier ScienceDirect Journals Complete
(32)
MEDLINE
(2)

Menü

Weitere Dienste

Einstellungen

The implications of hypersomnia in the context of major depression: Results from a large, international, observational study

C.04.03 Treating the whole patient: understanding the complexities of bipolar disorder

Hypomanic symptoms in mixed depression: is DSM-5 wrong? Evidence from the BRIDGE-II MIX study

P.3.e.014 VALID: a 12-week, open, randomised trial of valproate and lithium in bipolar I patients suffering from a manic episode

Lamotrigine in the treatment of bipolar depression

Psychomotor symptoms in major depressive episode are related to bipolarity. A pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts

P.332 Deconstructing major depressive episodes by severity and chronicity: A cross-diagnostic cluster-analysis on a large, international, observational study

C.17.02 Valproate in mania: from Pierre Lambert to New Deli Study

P.2.e.016 Sensitivity of a comprehensive rating scale for bipolar disorders to assess improvements with treatment

E.04.02 The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines

P.3.a.030 A 6-month, double-blind trial of ziprasidone plus a mood stabilizer in subjects with bipolar I disorder

P.2.e.026 Valproate for acute bipolar depression: systematic review and meta-analysis

Lamotrigine in bipolar depression and rapid cycling

Advances on prophylactics of bipolar disorder

Risperidone treatment for acute mania: assessment of tolerability

P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorder

P.1.210 Concomitant use of lamotrigine and valproate in bipolar I disorder

P.1.212 Effects of lithium and lamotrigine on body weight after 18 months in bipolar I disorder

Adjunctive risperidone in acute mania: A combined efficacy analysis

Risperidone plus mood stabilizer versus placebo plus mood stabilizer in patients with bipolar disorder: A combined efficacy analysis

Use of risperidone in psychotic and non-psychotic patients with bipolar disorder

ECNP Consensus Meeting March 2000 Nice: Guidelines for Investigating Efficacy in Bipolar Disorder

P.1.216 Lamotrigine but not lithium prevents or delays depressive episodes in bipolar I disorder

P.1.217 Predictors of response to lithium and lamotrigine prophylaxis in bipolar I disorder

P.1.213 Safety and tolerability of lamotrigine in bipolar I disorder

Aktive Filter

Suchergebnisse filtern